Skip to main content
SpringerLink
Log in

Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

A single intravenous dose of cimetidine 200mg was administered to 6 patients with severe chronic renal failure one hour prior to haemodialysis. The plasma concentrations of cimetidine and its sulphoxide metabolite at the start of haemodialysis were 2.74±0.12 and 0.76±0.08 µg/ml, and after dialysis for 4h 1.08±0.10 and 0.51±0.08 µg/ml, respectively (mean ± SE). The average haemodialysis clearance (ClHDa) of cimetidine during dialysis was 46–92ml/min at a dialysate flow rate of 320ml/min and blood flow rates in the 6 patients between 160–240ml/min. The mean ClHDa of the sulphoxide metabolite was 44% higher than that of cimetidine, and ranged between 49–148ml/min. During haemodialysis the mean plasma elimination half-life (t1/2) of cimetidine was 3.24h (range 2.08–5.08) and of the sulphoxide metabolite 9.49h (range 4.70–14.39). There was a significant relationship between the elimination rate constant (β) and ClHDa of the sulphoxide metabolite (p<0.01), but no such relationship was found between β and ClHDa of cimetidine. However, there was a tendency to a relationship between β of cimetidine and the capacity to metabolise the drug, expressed as the ratio between the plasma concentrations of the sulphoxide metabolite and cimetidine after dialysis for 4h. These ratios ranged between 0.23–0.76, and the lowest ratio was seen in the patient with the lowest β value of cimetidine. Thus, the large variations in the plained by differences in their capacity to metabolise the drug. The mean total amount of cimetidine eliminated during dialysis was 27.3mg (range 17.9–31.8), which was 9.0–15.9% of the given dose. Between 12.2–21.2mg (mean 15.3) of the sulphoxide metabolite was eliminated in the dialysate. Major adjustment of the dose of cimetidine on days of dialysis is not necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Doherty CC, O'Connor FA, Buchanan KD, Sloan JM, Ardill JES, Mc Geown MG (1977) Peptic ulcer in renal failure. Abstract. Br Soc Gastroenterol 59

  2. Shepherd AMM, Stewart WK, Wormsley KG (1973) Peptic ulceration in chronic renal failure. Lancet 1: 1357–1359

    Google Scholar 

  3. Ventkateswaran PS, Jeffers A, Hocken AG (1972) Gastric acid secretion in chronic renal failure. Br Med J 4: 22–23

    Google Scholar 

  4. Doherty CC, O'Connor FA, Buchanan KD, Mc Geown MG (1977) Cimetidine for duodenal ulceration in patients undergoing haemodialysis. Br Med J 2: 1506–1508

    Google Scholar 

  5. Jones RH, Levin MR, Parsons V (1979) Therapeutic effect of cimetidine in patients undergoing haemodialysis. Br Med J 1: 650–652

    Google Scholar 

  6. Bodemar G, Norlander B, Walan A (1981) Pharmacokinetics of cimetidine after single doses and during continuous treatment. Clin Pharmacokinet 6: 306–315

    Google Scholar 

  7. Burland WL, Duncan WAM, Hesselbo T, Mills JG, Sharpe PC, Haggie SJ, Wyllie JH (1975) Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. Br J Clin Pharmacol 2: 481–486

    Google Scholar 

  8. Somogyi A, Rohner H-G, Gugler R (1980) Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients. Clin Pharmacokinet 5: 84–94

    Google Scholar 

  9. Walkenstein SS, Dubb JW, Randolph WC, Westlake WJ, Stote RM, Intoccia AP (1978) Bioavailability of cimetidine in man. Gastroenterology 74: 360–365

    Google Scholar 

  10. Griffiths R, Lee RM, Taylor DC (1977) Kinetics of cimetidine in man and experimental animals. In: Burland WL, Simkins MA (eds) Cimetidine. Excerpta Medica, Amsterdam, pp 38–51

    Google Scholar 

  11. Spence RW, Celestin LR, De la Guardia R, Mac Mullen CA, Mc Cormick DA (1977) Short communication: Biliary secretion of cimetidine in man. In: Burland WL, Simkins MA (eds) Cimetidine Excerpta Medica, Amsterdam, pp 81–84

    Google Scholar 

  12. Taylor DC, Cresswell PR, Bartlett DC (1978) The metabolism and elimination of cimetidine, a histamine H2-receptor antagonist, in the rat, dog and man. Drug Metabol Disposit 6: 21–30

    Google Scholar 

  13. Ma KW, Brown DC, Masler DS, Silvis SE (1978) Effects of renal failure on blood levels of cimetidine. Gastroenterology 74: 473–477

    Google Scholar 

  14. Larsson R, Bodemar G, Norlander B (1979) Oral absorption of cimetidine and its clearance in patients with renal failure. Eur J Clin Pharmacol 15: 153–157

    Google Scholar 

  15. Larsson R, Norlander B, Bodemar G, Walan A (1981) Steady state kinetics and dosage requirements of cimetidine in renal failure. Clin Pharmacokinet 6: 316–325

    Google Scholar 

  16. Canavan JSF, Briggs JD (1977) Cimetidine clearance in renal failure. In: Burland WL, Simkins MA (eds) Cimetidine. Excerpta Medica, Amsterdam, pp 75–80

    Google Scholar 

  17. Vaziri ND, Ness RL, Barton CH (1978) Hemodialysis clearance of cimetidine. Arch Intern Med 138: 1685–1686

    Google Scholar 

  18. Fawcett JK, Scott JE (1960) A rapid and precise method for the determination or urea. J Clin Pathol 13: 156–159

    Google Scholar 

  19. Lee RM, Osborne PM (1978) High-pressure liquid chromatographic determination of cimetidine sulphoxide in human blood and urine. J Chromatogr 146: 354–360

    Google Scholar 

  20. Strouth L (1980) Personal communication

  21. Wolf AV, Remp DG, Kiley JE, Currie GD (1951) Artificial kidney function: Kinetics of hemodialysis. J Clin Invest 30: 1062–1070

    Google Scholar 

  22. Sargent JA, Gotch FA (1978) Principles and biophysics of dialysis. In: Drukker W, Parsons FM, Maher JF (eds) Replacement of renal function by dialysis. Martinus Nijhoff, Hague, pp 38–68

    Google Scholar 

  23. Lee CS, Marbury TC, Benet LZ (1980) Clearance calculations in hemodialysis: Application to blood, plasma and dialysate measurements for ethambutol. J Pharmacokinet Biopharmaceut 8: 69–81

    Google Scholar 

  24. Gibson TP, Matusik E, Nelson LD, Briggs WA (1976) Artificial kidneys and clearance calculations. Clin Pharmacol Ther 20: 720–726

    Google Scholar 

  25. Krichman KH, Cutler RE, Blair AD (1979) Pharmacokinetics of cimetidine in normal and uremic humans. Clin Res 27: 1, 73A

    Google Scholar 

  26. Randolph WC, Osborne VL, Intoccia AP (1980) Cimetidine sulphoxide: Whole blood levels in normal human subjects and patients with varying degrees of renal failure. Pharmacologist 22: 278, 649A

    Google Scholar 

  27. Puurunen J, Sotaniemi E, Pelkonen O (1980) Effect of cimetidine on microsomal drug metabolism in man. Eur J Clin Pharmacol 18: 185–187

    Google Scholar 

  28. Flind AC (1978) Cimetidine and oral anticoagulants. Lancet 2: 1054

    Google Scholar 

  29. Silver BA, Bell WR (1979) Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Ann Int Med 90: 348–349

    Google Scholar 

  30. Sjöqvist F, von Bahr C (1973) Interindividual differences in drug oxidation: Clinical importance. Drug Metabol Disposit 1: 469–482

    Google Scholar 

  31. Levi AJ, Sherlock S, Walker D (1968) Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet 1: 1275–1279

    Google Scholar 

  32. Maddocks JL, Wake CJ, Harber MJ (1975) The plasma half-life of antipyrine in chronic uremic and normal subjects. Br J Clin Pharmacol 2: 339–343

    Google Scholar 

  33. Testa B, Jenner P (eds) (1976) Drug metabolism: Chemical and biochemical aspects. Marcel Decker, New York, pp 298

    Google Scholar 

  34. Delaney JC, Ravey M (1977) Cimetidine and mental confusion. Lancet 2: 512

    Google Scholar 

  35. Grave W, Nadorp JHSM, Rutten JJMH (1977) Cimetidine and renal failure. Lancet 2: 719–720

    Google Scholar 

  36. Vickery TR (1978) Cimetidine reaction. Drug Intell Clin Pharmacol 12: 242

    Google Scholar 

  37. Wood CA, Isacson ML, Hibbs MS (1978) Cimetidine and mental confusion. J Am Med Assoc 239: 2550–2551

    Google Scholar 

  38. Schentag JJ, Cerra FB, Calleri G, De Glopper E, Rose JQ, Bernhard H (1979) Pharmacokinetic and clinical studies in patients with cimetidine — associated mental confusion. Lancet 1: 177–181

    Google Scholar 

  39. Mills JG, Smith, Kline and French Research Ltd (1981) Personal communication

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, University Hospital of Linköping, Linköping, Sweden

    R. Larsson & P. Erlanson

  2. Department of Internal Medicine, University Hospital of Linköping, Linköping, Sweden

    G. Bodemar

  3. Department of Clinical Pharmacology, University Hospital of Linköping, Linköping, Sweden

    B. Norlander & L. Fransson

  4. Department of Medical Engineering, University Hospital of Linköping, Linköping, Sweden

    L. Strouth

Authors
  1. R. Larsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Erlanson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Bodemar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Norlander
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Fransson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Strouth
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Larsson, R., Erlanson, P., Bodemar, G. et al. Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis. Eur J Clin Pharmacol 21, 325–330 (1982). https://doi.org/10.1007/BF00637621

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00637621

Key words

Search

Navigation